FUNCTIONAL-STUDIES WITH A FULL-LENGTH P-GLYCOPROTEIN CDNA ENCODED BY THE HAMSTER PGP1 GENE

被引:0
|
作者
DEVINE, SE
MELERA, PW
机构
[1] UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,MOLEC & CELL BIOL GRAD PROGRAM,BALTIMORE,MD 21201
[2] UNIV MARYLAND,CTR CANC,SCH MED,BALTIMORE,MD 21201
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hamster cells grown in culture may, like human and mouse cells, develop multidrug resistance (MDR) when exposed to certain cytotoxic chemotherapeutic agents. Several phenotypic features that are characteristic of MDR have been described; these include (1) resistance to many structurally and functionally unrelated drugs that have different cellular targets and modes of action; (2) reversal of MDR by certain agents, including verapamil and cyclosporin A; and (3) reduced intracellular drug accumulation relative to that of drug-sensitive cells. In this report we show that the introduction and overexpression of the hamster pgp1 cDNA confers to otherwise drug-sensitive cells an MDR phenotype with these features. Moreover, pgp1 transfectants showed varying degrees of resistance to anthracycline analogues, indicating that structural analogues of commonly used anticancer agents are capable of circumventing drug resistance conferred by pgp.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 50 条
  • [1] THE HAMSTER P-GLYCOPROTEIN GENE FAMILY CONTAINS 3 MEMBERS PGP1, PGP2 AND PGP3
    NG, W
    SARANGI, F
    ZASTAWNY, R
    LING, V
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 308 - 308
  • [2] STRUCTURAL AND FUNCTIONAL-ANALYSIS OF 5' FLANKING AND INTRON-1 SEQUENCES OF THE HAMSTER P-GLYCOPROTEIN PGP1 AND PGP2 GENES
    ZASTAWNY, RL
    LING, V
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1173 (03) : 303 - 313
  • [3] ANALYSIS OF THE CHINESE-HAMSTER P-GLYCOPROTEIN MULTIDRUG RESISTANCE GENE PGP1 REVEALS THAT THE AP-1 SITE IS ESSENTIAL FOR FULL PROMOTER ACTIVITY
    TEETER, LD
    ECKERSBERG, T
    TSAI, Y
    KUO, MT
    CELL GROWTH & DIFFERENTIATION, 1991, 2 (09): : 429 - 437
  • [4] Dynamics of the full-length P-glycoprotein in the POPC bilayer
    不详
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2005, 34 (06): : 804 - 804
  • [5] Dynamics of the full-length P-glycoprotein in the POPC bilayer.
    Tu, HH
    Lin, JH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U771 - U771
  • [6] Full length and alternatively spliced pgp1 transcripts in multidrug-resistant chinese hamster lung cells
    Devine, Scott E.
    Hussain, Arif
    Davide, Joseph P.
    Melera, Peter W.
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (266):
  • [7] Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes
    Park, SooHyun
    Majd, Sheereen
    PLOS ONE, 2018, 13 (06):
  • [8] Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
    Wang, Gangyang
    Cao, Lingling
    Jiang, Yafei
    Zhang, Tao
    Wang, Hongsheng
    Wang, Zhuoying
    Xu, Jing
    Mao, Min
    Hua, Yingqi
    Cai, Zhengdong
    Ma, Xiaojun
    Hu, Shuo
    Zhou, Chenghao
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [9] FULL LENGTH AND ALTERNATIVELY SPLICED PGP1 TRANSCRIPTS IN MULTIDRUG-RESISTANT CHINESE-HAMSTER LUNG-CELLS
    DEVINE, SE
    HUSSAIN, A
    DAVIDE, JP
    MELERA, PW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (07) : 4545 - 4555
  • [10] NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function
    Ye, Shunan
    Zhang, Jianming
    Shen, Jacson
    Gao, Yan
    Li, Ying
    Choy, Edwin
    Cote, Gregory
    Harmon, David
    Mankin, Henry
    Gray, Nathanael S.
    Hornicek, Francis J.
    Duan, Zhenfeng
    BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (03) : 613 - 626